TGA Consultation Regulation Impact Statement: Regulating the advertising of therapeutic goods to the general public

It’s hard to take TGA “reform” seriously when progress is so slow. The latest consultation document comes over a decade after concerns (and reform suggestions) about therapeutic goods advertising (especially the promotion of complementary medicines) was first raised.

Table 1. History of  advertising regulatory reform

Date Initiative
2002 Report of a Review of Advertising Therapeutic Products in Australia and New Zealand
2003 Report of Expert Committee on Complementary Medicines in the Health System
2005 Description of the joint (Trans-Tasman) regulatory scheme for the advertising of therapeutic products
2007 Consultation – draft (Trans-Tasman) advertising rule
2008 MJA paper. Commercialism, choice and consumer protection: regulation of complementary medicines in Australia
2010 TGA Consultation: Improving advertising arrangements for therapeutic goods

TGA Consultation: Reforms in the medical devices regulatory framework

2011 Consultation and Report of the Working Group on Promotion of Therapeutic Products

Report of the Review to improve the transparency of the Therapeutic Goods Administration

ANAO Report. Therapeutic Goods Regulation: Complementary Medicines

TGA reforms: A blueprint for TGA’s future

2012 Delivering reforms – Implementation plan for TGA Reforms

TGA Advertising regulatory framework: Options for reform

2013 TGA Consultation Regulation Impact Statement: Regulating the advertising of therapeutic goods to the general public

After consideration of public comment on this latest document, the TGA have said they will then prepare a final RIS to assist Government consideration of proposed regulatory reforms.

Meanwhile, as they have done for the last decade, it seems advertisers will be able to continue to breach the Therapeutic Goods Advertising Code with impunity for some time to come!

 

linkedinrsslinkedinrssby feather

About Dr Ken Harvey

Public Health Physician, Medical activitist
This entry was posted in Complementary medicine, Pharmaceutical Promotion and tagged , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.